Gene & Cell Limited in London, W1B 3HH

Description

Data updated on: 01-11-2023

Gene & Cell is a business situated at W1B 3HH London at 207 Regent Street. This business has been registered in year 2014 and is registered under the registration number 08983809. This business has been operating on the British market for 10 years now and the current status is active. The enterprise's principal business activity number is 72110 which means Research and experimental development on biotechnology. Gene & Cell Ltd reported its latest accounts for the period that ended on 2022-04-30. The business latest confirmation statement was filed on 2023-04-08.

For the following business, the full extent of director's tasks have so far been met by Panagiotis A. who was selected to lead the company in 2014 in April.

Panagiotis A. is the individual with significant control over this firm, owns over 3/4 of company shares and has 3/4 to full of voting rights.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2015-04-30	2016-04-30	2017-04-30	2018-04-30	2019-04-30	2020-04-30	2021-04-30	2022-04-30	2023-04-30
Currency
Net Worth	1 858	183	-155

Balance Sheet
Current Assets	1 858	183	203	174				40	2 586
Net Assets Liabilities			-804	174	174	100	100	40	2 586
Cash Bank On Hand				174	174	100	100
Cash Bank In Hand	1 858	183
Net Assets Liabilities Including Pension Asset Liability	1 858	183	-155

Capital & Reserves
Called Up Share Capital	1	1
Profit Loss Account Reserve	1 857	182
Shareholder Funds	1 858	183	-155

Other Financial Data
Average Number Employees During Period									1
Creditors			890	1 640
Net Current Assets Liabilities	1 858	183	-155	-1 466				40	2 586
Profit Loss									1 818
Tax Tax Credit On Profit Or Loss On Ordinary Activities									426
Total Assets Less Current Liabilities	1 858	183	-155	-1 466				40	2 586
Turnover Revenue									2 244
Number Shares Allotted	1 858	1			1	1	1
Par Value Share	1	1			174	100	100
Creditors Due Within One Year			358
Share Capital Allotted Called Up Paid	1	1

Company staff

Panagiotis A.

Role: Director

Appointed: 08 April 2014

Latest update: 25 March 2024

People with significant control

Panagiotis A.

Notified on 8 April 2016

Nature of control:

over 3/4 of shares

3/4 to full of voting rights

Accounts Documents

Account next due date	31 January 2024
Account last made up date	30 April 2022
Confirmation statement next due date	22 April 2024
Confirmation statement last made up date	08 April 2023

Annual Accounts 5 January 2016
Start Date For Period Covered By Report	2014-04-08
End Date For Period Covered By Report	2015-04-30
Date Approval Accounts	5 January 2016
Annual Accounts 30 January 2017
Start Date For Period Covered By Report	2015-05-01
End Date For Period Covered By Report	2016-04-30
Date Approval Accounts	30 January 2017
Annual Accounts
Start Date For Period Covered By Report	2016-05-01
End Date For Period Covered By Report	2017-04-30
Annual Accounts
Start Date For Period Covered By Report	01 May 2017
End Date For Period Covered By Report	30 April 2018
Annual Accounts
Start Date For Period Covered By Report	01 May 2017
End Date For Period Covered By Report	30 April 2018
Annual Accounts
Start Date For Period Covered By Report	01 May 2017
End Date For Period Covered By Report	30 April 2018
Annual Accounts
Start Date For Period Covered By Report	01 May 2017
End Date For Period Covered By Report	30 April 2018
Annual Accounts
Start Date For Period Covered By Report	01 May 2022
End Date For Period Covered By Report	30 April 2023
Annual Accounts 31 January 2018
Date Approval Accounts	31 January 2018

Gene & Cell Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Panagiotis A.

People with significant control

Panagiotis A.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies